Case number 1:23-cv-01157
Hikma Pharmaceuticals USA Inc. v. Cipla USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 6, 2024 | N/A | SO ORDERED, re 26 Stipulation and Order to Stay All Deadlines Pending Settlement filed by Hikma Pharmaceuticals USA Inc., Case stayed. Signed by Judge Gregory B. Williams on 6/6/2024. (lnb) (Entered: 06/06/2024) (0) |
| Jun 5, 2024 | 26 | STIPULATION to Stay all Deadlines Pending Settlement by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 06/05/2024) (2) |
| May 29, 2024 | 25 | NOTICE OF SERVICE of (i) Plaintiff Hikma Pharmaceutical USA Inc.'s Rule 26(a) Initial Disclosures; and (ii) Plaintiff Hikma Pharmaceutical USA Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 05/29/2024) (2) |
| May 29, 2024 | 24 | NOTICE OF SERVICE of (1) Cipla's Rule 26(a)(1) Initial Disclosures and (2) Cipla's Paragraph 3 Disclosures filed by Cipla Limited, Cipla USA, Inc..(Dorsney, Kenneth) (Entered: 05/29/2024) (2) |
| May 28, 2024 | N/A | SO ORDERED, re 23 STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 5, 2024 filed by Hikma Pharmaceuticals USA Inc. Signed by Judge Gregory B. Williams on 5/28/2024. (lnb) (Entered: 05/28/2024) (0) |
| May 24, 2024 | 23 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 5, 2024 - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 05/24/2024) (2) |
| Apr 26, 2024 | 22 | ORAL ORDER: Given the Stipulation and Proposed Order to Amend the Scheduling Order agreed to by the parties, and the Court's approval thereof, the Hearing on Claim Construction is HEREBY RESCHEDULED from January 8, 2025, at 1:00 pm, to January 23, 2025, at 1:00 pm. The parties shall deliver to Chambers two (2) courtesy copies of any slides to be used during the hearing by no later than 1:00 pm on January 22, 2025. ORDERED by Judge Gregory B. Williams on 4/26/24. (ntl) (Entered: 04/26/2024) (0) |
| Apr 26, 2024 | 21 | SO ORDERED, re 20 Stipulation and Order to Amend the Scheduling Order -- Joint Claim Construction Brief due by 12/20/2024. The Markman Hearing is RESCHEDULED for 1/23/2025 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 4/26/24. (ntl) (Entered: 04/26/2024) (2) |
| Apr 25, 2024 | 20 | STIPULATION to Amend the Scheduling Order by Cipla Limited, Cipla USA, Inc.. (Dorsney, Kenneth) (Entered: 04/25/2024) (2) |
| Mar 18, 2024 | 19 | ORAL ORDER: IT IS HEREBY ORDERED that the teleconference scheduled for March 19, 2024 is CANCELLED. ORDERED by Judge Gregory B. Williams on 3/18/24. (ntl) (Entered: 03/18/2024) (0) |
| Mar 15, 2024 | 18 | SCHEDULING ORDER: Fact Discovery completed by 1/31/2025. Status Report due by 12/20/2024. Joint Claim Construction Brief due by 12/5/2024. A Markman Hearing is set for 1/8/2025 at 01:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Final Pretrial Conference is set for 10/1/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set for 10/6/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 3/15/24. (ntl) (Entered: 03/15/2024) (13) |
| Mar 13, 2024 | 17 | Letter to The Honorable Gregory B. Williams from Dominick T. Gattuso, Esquire regarding [Proposed] Scheduling Order. (Attachments: # 1 Text of Proposed Order [Proposed] Scheduling Order)(Gattuso, Dominick) (Entered: 03/13/2024) (0) |
| Mar 7, 2024 | 16 | ORAL ORDER: IT IS HEREBY ORDERED that, by 5:00 PM on March 13, 2024, the parties shall meet and confer and submit to the Court a joint proposed scheduling order consistent with my Form Scheduling Order [Patent, ANDA] found on the Court's website. The Court will hold a scheduling and status teleconference on Tuesday, March 19, 2024, at 10:00 AM. Plaintiff shall coordinate the teleconference and provide the dial-in information to the Defendant and the Court no later than 10:00 AM on Monday, March 18, 2024. ORDERED by Judge Gregory B. Williams on 3/7/24. (ntl) (Entered: 03/07/2024) (0) |
| Jan 9, 2024 | 15 | ANSWER to 14 Amended Answer to Complaint, Counterclaim Hikma Pharmaceuticals USA Inc.'s Answer to Counterclaims by Hikma Pharmaceuticals USA Inc..(Gattuso, Dominick) (Entered: 01/09/2024) (18) |
| Dec 19, 2023 | 14 | AMENDED ANSWER to 1 Complaint, COUNTERCLAIM Cipla's First Amended Answer and Counterclaims against Hikma Pharmaceuticals USA Inc. by Cipla Limited, Cipla USA, Inc.. (Dorsney, Kenneth) (Entered: 12/19/2023) (30) |
| Dec 19, 2023 | N/A | SO ORDERED, re 13 Stipulation and Order to Amend Answer and Counterclaims filed by Cipla Limited, Cipla USA, Inc. Signed by Judge Gregory B. Williams on 12/19/23. (ntl) (Entered: 12/19/2023) (0) |
| Dec 18, 2023 | 13 | STIPULATION for Cipla to file a First Amended Answer and Counterclaims and extending Hikma's response to Cipla's Amended Answer and Counterclaims by Cipla Limited, Cipla USA, Inc.. (Dorsney, Kenneth) (Entered: 12/18/2023) (30) |
| Dec 18, 2023 | N/A | Pro Hac Vice Attorney Marsha Rose Gillentine, Robert E. Niemeier, Uma N. Everett, Dennies Varughese, and Alexander V. Alfano for Cipla Limited and Cipla USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/18/2023) (0) |
| Dec 13, 2023 | N/A | SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney Alexander Vincent Alfano, Attorney Uma Everett, Attorney Marsha Rose Gillentine, Attorney Robert E. Niemeier, and Attorney Dennies Varughese filed by Cipla Limited, Cipla USA, Inc. Signed by Judge Gregory B. Williams on 12/13/23. (ntl) (Entered: 12/13/2023) (0) |
| Dec 12, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Alexander Vincent Alfano, Attorney Uma Everett, Attorney Marsha Rose Gillentine, Attorney Robert E. Niemeier, and Attorney Dennies Varughese - filed by Cipla Limited, Cipla USA, Inc.. (Dorsney, Kenneth) (Entered: 12/12/2023) (7) |
| Dec 5, 2023 | N/A | Pro Hac Vice Attorney Annie R. Steiner for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/05/2023) (0) |
| Dec 4, 2023 | N/A | Pro Hac Vice Attorney Sharon Lin for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 12/04/2023) (0) |
| Nov 6, 2023 | 11 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent InvaGen Pharmaceuticals, Inc., Corporate Parent Cipla Limited, Corporate Parent Cipla (EU Limited) for Cipla USA, Inc. filed by Cipla Limited, Cipla USA, Inc.. (Dorsney, Kenneth) (Entered: 11/06/2023) (2) |
| Nov 6, 2023 | 10 | ANSWER to 1 Complaint by Cipla Limited, Cipla USA, Inc..(Dorsney, Kenneth) (Entered: 11/06/2023) (20) |
| Oct 24, 2023 | N/A | Pro Hac Vice Attorney Charles B. Klein for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 10/24/2023) (0) |
| Oct 24, 2023 | N/A | Pro Hac Vice Attorney Jovial Wong for Hikma Pharmaceuticals USA Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 10/24/2023) (0) |
| Oct 24, 2023 | N/A | SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Sharon Lin, and Annie R. Steiner of Winston & Strawn LLP filed by Hikma Pharmaceuticals USA Inc. Signed by Judge Gregory B. Williams on 10/23/23. (ntl) (Entered: 10/24/2023) (0) |
| Oct 18, 2023 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Sharon Lin, and Annie R. Steiner of Winston & Strawn LLP - filed by Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick) (Entered: 10/18/2023) (7) |
| Oct 18, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (nms) (Entered: 10/18/2023) (0) |
| Oct 16, 2023 | 8 | SUMMONS Returned Executed by Hikma Pharmaceuticals USA Inc..Cipla USA, Inc. served on 10/16/2023, answer due 11/6/2023. (Gattuso, Dominick) (Entered: 10/16/2023) (2) |
| Oct 16, 2023 | 7 | SUMMONS Returned Executed by Hikma Pharmaceuticals USA Inc..Cipla Limited served on 10/16/2023, answer due 11/6/2023. (Gattuso, Dominick) (Entered: 10/16/2023) (2) |
| Oct 13, 2023 | 6 | Summons Issued as to Cipla USA, Inc. on 10/13/2023. (smg) (Entered: 10/13/2023) (2) |
| Oct 13, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals PLC for Hikma Pharmaceuticals USA Inc. filed by Hikma Pharmaceuticals USA Inc. (smg) (Entered: 10/13/2023) (2) |
| Oct 13, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,722,510; 10,973,814; 11,135,155; 11,617,713; and 11,628,139. (smg) (Entered: 10/13/2023) (1) |
| Oct 13, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 30, 2023. Date of Expiration of Patent: August 26, 2034. Thirty Month Stay Deadline: 3/2/2026. (smg) (Entered: 10/13/2023) (1) |
| Oct 13, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) (Entered: 10/13/2023) (3) |
| Oct 13, 2023 | 1 | Complaint* (1) |
